The Economic Burden of the Obesity in Brazil (Published)
Almost one in two people in Brazil is currently obese. Obesity in adults reduces life expectancy, increases health care costs, decreases work performance, and consequently, decreases the GDP. Therefore, we addressed the economic significance of obesity in Brazil. The Brazilian Government has made some policies to promote healthy lifestyles to challenge this international public health dilemma. The article evaluated policies that could significantly improve public health outcomes. Discussion and future research compile the present study.
Citation: Karina Contis Costa, Murillo de Oliveira Dias, Raphael de Oliveira Albergarias Lopes, Jorge Cardoso (2021) The Economic Burden of the Obesity in Brazil, European Journal of Biology and Medical Science Research , Vol.9, No.4, pp.35-47,
Keywords: Obesity, economic burden., overweight, public health care
American Intragastric Balloons Are Safe and Effective For Weight Reduction (Published)
The bioenteric balloon (BIB) or spatzs ballon are widely applied in the management of obesity. This is a report on the efficacy and safety of Ballon device in the first 106 cases. Patients referred for Balloon between 2015 till 2016 were evaluated retrospectively. Balloon was inserted for 6 months according to predetermined inclusion and exclusion criteria. In 106 cases, 22 cases were males (16.8%) and 84 cases were females (83.2%), mean age 33.2 (±10.44) years, mean BMI 35.9 (±4.65) kg/m2. None of the patients exhibited balloon migration or perforation. The balloon was removed upon request in 3 patients due to exaggerated intolerance (2.9%). The mean weight loss was 15.5 kg (±4.67), mean EWL 64.12% (±23.48%). The mean BMI at extraction was 29.7 kg/m2 (±4.48) with a BMI loss of 6.2 kg/m2 (±2.0). 87 patients (88.7%) achieved target EWL (32.1% of excess weight), and 87 patients lost >12.2% of their basal weight (88.7%). 70 patients achieved BMI loss >5.7 kg/m2 (71.4%). BIB and spatzs balloon achieves acceptable success with minimal complications. In further long term, prospective studies are needed to evaluate obesity related comorbidities when using such modality and to compare it to other available devices.
Keywords: American Balloon, Bioenteric Balloon, Obesity, Weight Loss, spatzs balloon
The Prevalence of Vitamin D Deficiency among Overweight and Obese Individuals (Published)
Objective: Vitamin D deficiency and obesity are widely spread and were associated with chronic diseases. The goal of our study is to evaluate the prevalence of vitamin D deficiency in obese individuals and its association with the metabolic parameter. Method:A cross sectional study of individuals attending diet center located in Taif, Saudi Arabia, conducted between October 2015 and June 2016. We included those with BMI >25 and have vitamin D level. Vitamin D ≤ 20 ng/ml was considered to be deficient. Result:A total of 148 participants were enrolled with a mean age of 36 years, mainly female and married .The mean weight was 95.9 kg, mean BMI of 37.3 Kg/m2, 94.6% were obese, and the mean vitamin D level was 15.7. Compared to those who are vitamin D sufficient ,those who are deficient were more likely to have class III obesity (p 0.891), exercise <150 min per week (p 0.453), have asthma (P 0.149), have higher mean total cholesterol level (p 0.310) and higher mean fasting blood glucose (p 0.632). Partial correlation adjusting for age, gender, exercise, diabetes, and hypertension showed non-significant negative correlation between vitamin D and BMI (r -.121, p0.202), vitamin D and cholesterol (r -.039, p 0.678) and vitamin D and blood glucose (r -.122, p 0.198).Conclusion: Non-significant negative correlation was found between BMI and vitamin D level, the average vitamin D level in overweight group was 21 ng/ml while the average in obese class 3 was 15 ng/ml.
Keywords: Obesity, Vitamin D, Weight Loss, diet
Weight Loss by Intragastric Balloon (Published)
Introduction: The bioenteric balloon (BIB) or spatzs ballon are widely applied in the management of obesity.Aim of the work: This is a report on the efficacy and safety of Ballon device in the first 101 cases.Methods: Patients referred for Balloon between 2014 till 2015 were evaluatedretrospectively. Balloon was inserted for 6 months according to predetermined inclusion and exclusion criteria. Results: In 101 cases, 17 cases were males (16.8%) and 84 cases were females (83.2%), mean age 33.2 (±10.44) years, mean BMI 35.9 (±4.65) kg/m2. None of the patients exhibitedballoon migration or perforation. The balloon was removed upon request in 3 patients dueto exaggerated intolerance (2.9%). The mean weight loss was 15.5 kg (±4.67), mean EWL 64.12% (±23.48%). The mean BMI at extraction was 29.7 kg/m2 (±4.48) with a BMI loss of 6.2 kg/m2 (±2.0). 87 patients (88.7%) achieved target EWL (32.1% of excess weight), and 87 patients lost >12.2% of their basal weight (88.7%). 70 patients achieved BMI loss >5.7 kg/m2 (71.4%). Conclusion: BIB and spatzs balloon achieves acceptable success with minimal complications. In further long term, prospective studies are needed to evaluate obesity related comorbidities when using such modality and to compare it to other available devices.
Keywords: Bioenteric Balloon, Obesity, Weight Loss, spatzs balloon
ANTERIOR PLICATED ALKADERI’S GASTROPLASTY: A NEW RESTRICTIVE BARIATRIC PROCEDURE (Published)
The obesity has become a serious problem of public health. It´s associated to an increase of the general morbid-mortality and it´s considered a risk factor of different illnesses. The bariatric surgery is one of the pillars in the obesity treatments; its main objective is the control of the weight, to reduce the comorbidities and in this way to improve the life quality and patients’ survival.
Keywords: Bariatric Surgery, Obesity, Restrictive Bariatric Surgery